Recombinant Anti-CEA x Anti-HSG Bispecific Antibody (scFv-CH1/CL) (BSCC-140)

Recombinant Anti-CEA x Anti-HSG Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-CEA antibody variable domain is fused to CH1 and the other scFv from an anti-HSG antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can be used in pretargeting system of PET, radioimaging or radiotherapy. It can mediate targeting of radioactivity to tumor cells. It is designed for the research of Breast cancer; Ovary cancer; Colon cancer; Lung cancer imaging and therapy.

Datasheet INQUIRY

Specifications

Targets

CEA & HSG

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Pretargeting system for radioimaging and radiotherapy

Related Disease

Breast cancer; Ovary cancer; Colon cancer; Lung cancer

Targets

Target 1

CEA

Gene ID

1048

UniProt ID

A0A024R0K5

Alternative Names

CEACAM5; carcinoembryonic antigen; carcinoembryonic antigen related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100

Target 2

HSG

Alternative Names

histaminyl-succinyl-glycine; HSG

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CEA x Anti-HSG Bispecific Antibody (scFv-CH1/CL) (BSCC-140). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CEA x Anti-HSG Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-140)

Specifications

Targets

Customer Reviews and Q&As